Shayan Owji

PGY-3 @MSHSDerm

[JAMA Oncology @JAMAOnc]

Among patients with immune checkpoint inhibitor–related cutaneous adverse events, dupilumab therapy was associated with lower 5-year mortality compared to no dupilumab or systemic corticosteroids.

https://t.co/7SaH03bhCb

[Healio Allergy and Asthma @HealioAllergy]

Patients on #dupilumab for atopic #dermatitis had significantly lower risks for internal malignancies than patients on other therapies, said Dr. Nicholas Gulati of @IcahnMountSinai. Also, @RajMDPhD comments.
@HealioDerm @EmmaGuttman
Read more 👇
https://t.co/D9LT8IcZQ2

[Miriam Merad, MD, PhD @MiriamMerad]

Very excited by our results @Nature showing that IL4R signaling is strongly enriched in myeloid cells that infiltrate mice and lung cancer lesions https://t.co/Nnjc7ue96y

[Healio Allergy and Asthma @HealioAllergy]

Incident rates included 12.88 for patients on #dupilumab and 15.04 among patients who were not taking the biologic, said Dr. Nicholas Gulati of @MountSinaiNYC. Also, Dr. Peter Lio of @NUFeinbergMed comments. @EmmaGuttman @OwjiShayan @HealioDerm
https://t.co/QowuJPh7T5

[James Diao @JamesADiao]

ChatGPT scored ~40-60% across the USMLEs. N is low (~100), so CIs are large (+/- 10%).

While promising, an LLM that underperforms 99% of med students under ideal conditions (answer choices given, complete info, and text only) has much room to grow.

https://t.co/wR6jLIEIKM

[Shayan Owji @OwjiShayan]

The vasoconstrictor assay is a useful technique for comparing potency/bioavailability of topical steroids. The catch? It depends on blanching & often excludes SOC. We explore using D-OCT to directly measure vasoconstriction in all skin types. #dermtwitter
https://t.co/wF0HZkITfI

[Shayan Owji @OwjiShayan]

Happy to share our recent work, a collab between @MSHSDerm & @TischCancer, examining #dupilumab’s role in treating rash from a key #myeloma drug and its impact on the malignancy itself. Always grateful for the mentorship of Dr. Nicholas Gulati #dermtwitter https://t.co/PUSa8OFUHt

[NatureRevClinOncol @NatRevClinOncol]

In a Review now online, @NicoleKuderer, @ADesaiMD, @maryam_lustberg and @gary_lyman explain the most common acute toxicities in patients with cancer receiving chemotherapy and discuss management options: https://t.co/WUcOXGTJ8I

[The New Yorker @NewYorker]

Inside this week’s issue of The New Yorker: https://t.co/qLUnr8B8S6

[Jennifer Choi, MD, FAAD @MDJenniferChoi]

Cutaneous side effects are one of the most common side effects to occur secondary to cancer treatment.

My colleague @MilanAnadkat is speaking for Patient Advocacy Strategies on EGFR inhibitor-induced skin side effects on 10/4.

Plz share with any pts & providers who may benefit!

[Mount Sinai Dermatology @MSHSDerm]

@OwjiShayan Such an important project!

[Shayan Owji @OwjiShayan]

Looking forward to presenting results from our study with Drs #JonathanUngar #BenjaminUngar #NicholasGulati at @MSHSDerm on a novel use of optical coherence tomography with promising implications for skin of color! Registration is free at https://t.co/7RB46fsujp

[BNO News @BNOFeed]

U.S. MONKEYPOX CASES:

- May 18: 1
- May 26: 10
- June 16: 100
- July 13: 1,000
- July 29: 5,000
- Aug. 10: 10,000
- Sept. 2: 20,000

[Avi Bitterman, MD @AviBittMD]

Cheek and neck of a 92-year-old female, who used UV-protective moisturizers on her face but not on the neck for 40+ years.

https://t.co/Q8wWxY2tDE